argenx NV ADR
Price & Volume
Stats
See more52W Range | $510.05-$934.62 |
Market Cap | $42.9B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $4.2B |
Revenue Growth (YoY) | 73% |
Gross Profit (12 Mos) | $2.4B |
Diluted EPS | $19.55 |
News
See moreYahoo Finance • 7 days ago
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
Yahoo Finance • 7 days ago
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch
Yahoo Finance • 12 days ago
Analysts Highlight Vyvgart Expansion as Major Growth Driver for Argenx (ARGX)
Yahoo Finance • 13 days ago
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
About
CEO | Mr. Timothy Van Hauwermeiren EMBA, M.Sc. |
Address | Laarderhoogtweg 25, Amsterdam, Netherlands, 1101 EB |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,863 |
